What is the dosage of nirmatrelvir (generic name) 150 mg and ritonavir (generic name) 100 mg for an adult patient with mild to moderate COVID-19, twice daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Paxlovid Dosing: Standard Regimen

A patient takes 3 tablets twice daily: two 150 mg nirmatrelvir tablets (total 300 mg) plus one 100 mg ritonavir tablet, taken together at approximately the same time each day for 5 days. 1

Standard Dosing for Normal Renal Function

  • Total daily intake: 6 tablets per day (3 tablets twice daily) 1
  • Per dose composition:
    • Nirmatrelvir: 300 mg (two 150 mg tablets)
    • Ritonavir: 100 mg (one 100 mg tablet) 1
  • Duration: 5 days of treatment 1
  • Timing: Administer at approximately the same time each day, with or without food 1
  • Treatment initiation: Must start within 5 days of symptom onset 2, 1

Dose Adjustments for Renal Impairment

Moderate renal impairment (eGFR 30-59 mL/min):

  • Reduced dose: 1 tablet of nirmatrelvir 150 mg plus 1 tablet of ritonavir 100 mg twice daily for all 5 days 2, 1
  • Total tablets per dose: 2 tablets (instead of 3) 1

Severe renal impairment (eGFR <30 mL/min) including hemodialysis:

  • Day 1: 2 tablets nirmatrelvir 150 mg (300 mg total) plus 1 tablet ritonavir 100 mg once daily 1
  • Days 2-5: 1 tablet nirmatrelvir 150 mg plus 1 tablet ritonavir 100 mg once daily 1
  • Hemodialysis timing: Administer after hemodialysis on dialysis days 1

Critical Safety Considerations

Drug interactions are the primary concern because ritonavir is a potent CYP3A inhibitor that can cause severe, life-threatening interactions with many medications 1:

  • Always check the Liverpool COVID-19 Drug Interaction Tool before prescribing 2, 3
  • Contraindicated with drugs highly dependent on CYP3A clearance 1
  • Interaction risk extends beyond the 5-day treatment period 3

Common pitfall: Failing to adjust dose for renal impairment—always assess eGFR before prescribing, as nirmatrelvir is primarily renally eliminated when co-administered with ritonavir 4, 5

References

Guideline

Cautions with Paxlovid (Nirmatrelvir/Ritonavir)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Paxlovid Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.